W Van Den Bogaert
Overview
Explore the profile of W Van Den Bogaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andelhofs D, Van Den Bogaert W, Lepla B, Croes K, Van de Voorde W
Forensic Sci Med Pathol
. 2023 Jun;
20(3):949-964.
PMID: 37351779
Sodium nitrite (NaNO) is an inorganic compound that is commonly used as a preservative (E250) in the fish and meat industry. When ingested, sodium nitrite will lead to methemoglobinemia, hypotension,...
2.
Allal A, Ares C, Dulguerov P, Tschanz E, Verdan C, Mhawech P, et al.
Strahlenther Onkol
. 2016 May;
180 Suppl 1:89-108.
PMID: 27137923
No abstract available.
3.
Wagemans J, Beuselinck B, Nuyts S, Sciot R, Delaere P, Vander Poorten V, et al.
Acta Clin Belg
. 2011 Jan;
65(6):404-10.
PMID: 21268954
Embryonal rhabdomyosarcoma (RMS) is a rare malignant mesenchymal tumour that is believed to arise from cells committed to a skeletal muscle lineage. The head and neck region is among the...
4.
Dieudonne A, Lambrechts D, Claes B, Vandorpe T, Wildiers H, Timmerman D, et al.
Breast Cancer Res Treat
. 2009 Jul;
118(3):531-8.
PMID: 19597703
Retrospective studies suggest that single nucleotide polymorphisms in the cytochrome P450 2D6 (CYP2D6) gene predict reduced tamoxifen metabolism, better tolerance and worse treatment outcome. We hypothesized that women with this...
5.
Neven P, Van Calster B, Van den Bempt I, Van Huffel S, Van Belle V, Hendrickx W, et al.
Breast Cancer Res Treat
. 2007 Aug;
110(1):153-9.
PMID: 17687649
Background: The negative association between the oestrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER-2) in breast cancer travels in both directions. ER+ tumours are less likely...
6.
Neven P, Paridaens R, Amant F, Wildiers H, Berteloot P, Leunen K, et al.
Int J Gynecol Cancer
. 2006 Oct;
16 Suppl 2:505-10.
PMID: 17010059
No abstract available.
7.
Ahmed B, Landuyt W, Griffioen A, van Oosterom A, Van Den Bogaert W, Lambin P
Anticancer Res
. 2006 Feb;
26(1A):307-10.
PMID: 16475711
Background: The study aimed at evaluating the potential benefit from a combination of fractionated ionising radiation with the vascular-targeting compound combretastatin A-4 phosphate (CA-4-P). Materials And Methods: Syngenic rat rhabdomyosarcoma...
8.
Goethals L, Haustermans K, Perneel C, Bussels B, DHoore A, Geboes K, et al.
Eur J Surg Oncol
. 2005 Jun;
31(9):969-76.
PMID: 15936170
Aim: To determine the differences in downstaging, local control (LC), disease free survival (DFS) and overall survival (OS) between combined pre-operative chemoradiation and pre-operative radiotherapy alone in the treatment of...
9.
Poortmans P, Kouloulias V, Venselaar J, Struikmans H, Davis J, Huyskens D, et al.
Eur J Cancer
. 2003 Sep;
39(14):2035-42.
PMID: 12957458
To assess consistency among participants in an European Organisation for Research and Treatment of Cancer (EORTC) phase III trial randomising between irradiation and no irradiation of the internal mammary and...
10.
Vrieling C, Collette L, Fourquet A, Hoogenraad W, Horiot J, Jager J, et al.
Eur J Cancer
. 2003 Apr;
39(7):932-44.
PMID: 12706362
The aim of this study was to identify patient-, tumour- or treatment-related factors associated with young age that might explain the higher risk of ipsilateral breast recurrence that occurs after...